Nilotinib hydrochloride

• Description:

  Nilotinib hydrochloride (AMN-107 HCl) is an orally available Bcr-Abl tyrosine kinase inhibitor with antitumor activity for modulation of neuroinflammation and cognitive deficits, and may be used in studies of chronic myelogenous leukemia.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  565.98

• Molecular Formula:

  C28H23ClF3N7O

• Notes:

  Research use only, not for human use.

• Receptor:

  Autophagy | Bcr-Abl

• CAS Number:

  923288-95-3